RSS Subscribe to our Nanotechnology Business News feed

Global Collaboration to Help Protect Medications From Counterfeiting and Illegal Diversion

NanoGuardian, a division of NanoInk that delivers brand protection solutions to defend against illegal diversion and counterfeiting, announced today that it entered into a license agreement with Capsugel, a division of Pfizer and the global leader in providing capsule-based drug delivery systems, that gives Capsugel global access to NanoGuardian's NanoEncryption technology for the protection of capsule-based medications against counterfeiting and illegal diversion.

Feb 22nd, 2010

Read more